Industry: Service & Software
Published Date: 2026-03-12
Pages: 136 Pages
Report ld: 6245431
Request Sample
Customized Report
Pet Genetic Screening Platform Market Size(US$)

CAGR 2026-2032
16.2%
Market Size,2032
USD 4,916
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Pet Genetic Screening Platform market was valued at US$ 1743 million in 2025 and is anticipated to reach US$ 4916 million by 2032, at a CAGR of 16.2% from 2026 to 2032.
In recent years, the gross profit margin of the pet genetic screening platform has been around 61%, with a gross profit of US$612 million.The pet genetic screening platform, based on high-throughput gene sequencing and bioinformatics analysis technologies, provides comprehensive testing and interpretation services for pets such as dogs and cats, including genetic defects, genetic disease susceptibility, breed traceability, and health risk assessment. By collecting oral swabs and blood samples from pets, the platform detects mutations and variations at specific gene loci. Combining database comparison with artificial intelligence analysis, it enables scientific assessment of congenital genetic diseases, recessive gene carriers, breed purity, and physical characteristics. This provides precise evidence for pet health management, breeding decisions, and personalized care, and is widely used in pet healthcare, pet insurance, pet breeding, and family pet health management.
As an emerging tool in pet healthcare and health management, pet genetic screening platforms are becoming a crucial resource for pet owners and veterinarians. Through genetic testing, they can identify potential genetic diseases, behavioral traits, and nutritional and metabolic predispositions in pets, thereby assisting owners with informed feeding, targeted prevention, and personalized care, while also providing veterinarians with more proactive diagnostic and treatment guidance. With the increasing number of pets, growing awareness of pet health management among owners, and the growing adoption of precision medicine, this sector presents enormous market potential. In the future, providers of pet genetic screening platforms should continuously optimize testing technology to enhance data accuracy and professional interpretation. They should also focus on collaborating with pet hospitals, pet insurance companies, and nutritional supplement manufacturers to form a closed loop of data and services and increase user retention. Regarding compliance and ethics, they should ensure data security and user privacy, and establish transparent and trustworthy service standards. Furthermore, providers should invest in public awareness and user education to help pet owners understand the value of genetic screening, thereby promoting the long-term and healthy development of the industry.
This report delivers a comprehensive overview of the global Pet Genetic Screening Platform market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Pet Genetic Screening Platform. The Pet Genetic Screening Platform market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Pet Genetic Screening Platform market comprehensively. Regional market sizes by Type, by Application, by Detection Species Range, and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Pet Genetic Screening Platform manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Detection Species Range, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Pet Genetic Screening Platform companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pet Genetic Screening Platform Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Single Gene Defect Screening Platform
1.2.3 Whole Genome Health Risk Screening Platform
1.3 Market by Detection Species Range
1.3.1 Global Pet Genetic Screening Platform Market Size Growth Rate by Detection Species Range: 2021 vs 2025 vs 2032
1.3.2 Dedicated Screening Platform for Dogs and Cats
1.3.3 Universal Screening Platform for All Pet Species
1.4 Market by Application
1.4.1 Global Pet Genetic Screening Platform Market Growth by Application: 2021 vs 2025 vs 2032
1.4.2 Medical Institutions
1.4.3 Pet Breeding Companies
1.4.4 Others
1.5 Assumptions and Limitations
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Pet Genetic Screening Platform Market Perspective (2021–2032)
2.2 Global Pet Genetic Screening Platform Growth Trends by Region
2.2.1 Global Pet Genetic Screening Platform Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Pet Genetic Screening Platform Historic Market Size by Region (2021–2026)
2.2.3 Pet Genetic Screening Platform Forecasted Market Size by Region (2027–2032)
2.3 Pet Genetic Screening Platform Market Dynamics
2.3.1 Pet Genetic Screening Platform Industry Trends
2.3.2 Pet Genetic Screening Platform Market Drivers
2.3.3 Pet Genetic Screening Platform Market Challenges
2.3.4 Pet Genetic Screening Platform Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pet Genetic Screening Platform Players by Revenue
3.1.1 Global Top Pet Genetic Screening Platform Players by Revenue (2021–2026)
3.1.2 Global Pet Genetic Screening Platform Revenue Market Share by Players (2021–2026)
3.2 Global Top Pet Genetic Screening Platform Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Pet Genetic Screening Platform Revenue
3.4 Global Pet Genetic Screening Platform Market Concentration Ratio
3.4.1 Global Pet Genetic Screening Platform Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pet Genetic Screening Platform Revenue in 2025
3.5 Global Key Players of Pet Genetic Screening Platform Head Offices and Areas Served
3.6 Global Key Players of Pet Genetic Screening Platform, Products and Applications
3.7 Global Key Players of Pet Genetic Screening Platform, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Pet Genetic Screening Platform Breakdown Data by Type
4.1 Global Pet Genetic Screening Platform Historic Market Size by Type (2021–2026)
4.2 Global Pet Genetic Screening Platform Forecasted Market Size by Type (2027–2032)
5 Pet Genetic Screening Platform Breakdown Data by Application
5.1 Global Pet Genetic Screening Platform Historic Market Size by Application (2021–2026)
5.2 Global Pet Genetic Screening Platform Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Pet Genetic Screening Platform Market Size (2021–2032)
6.2 North America Pet Genetic Screening Platform Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Pet Genetic Screening Platform Market Size by Country (2021–2026)
6.4 North America Pet Genetic Screening Platform Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Pet Genetic Screening Platform Market Size (2021–2032)
7.2 Europe Pet Genetic Screening Platform Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Pet Genetic Screening Platform Market Size by Country (2021–2026)
7.4 Europe Pet Genetic Screening Platform Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Pet Genetic Screening Platform Market Size (2021–2032)
8.2 Asia-Pacific Pet Genetic Screening Platform Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Pet Genetic Screening Platform Market Size by Region (2021–2026)
8.4 Asia-Pacific Pet Genetic Screening Platform Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Pet Genetic Screening Platform Market Size (2021–2032)
9.2 Latin America Pet Genetic Screening Platform Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Pet Genetic Screening Platform Market Size by Country (2021–2026)
9.4 Latin America Pet Genetic Screening Platform Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pet Genetic Screening Platform Market Size (2021–2032)
10.2 Middle East & Africa Pet Genetic Screening Platform Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Pet Genetic Screening Platform Market Size by Country (2021–2026)
10.4 Middle East & Africa Pet Genetic Screening Platform Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Wisdom Panel
11.1.1 Wisdom Panel Company Details
11.1.2 Wisdom Panel Business Overview
11.1.3 Wisdom Panel Pet Genetic Screening Platform Introduction
11.1.4 Wisdom Panel Revenue in Pet Genetic Screening Platform Business (2021–2026)
11.1.5 Wisdom Panel Recent Development
11.2 Embark Veterinary
11.2.1 Embark Veterinary Company Details
11.2.2 Embark Veterinary Business Overview
11.2.3 Embark Veterinary Pet Genetic Screening Platform Introduction
11.2.4 Embark Veterinary Revenue in Pet Genetic Screening Platform Business (2021–2026)
11.2.5 Embark Veterinary Recent Development
11.3 Basepaws
11.3.1 Basepaws Company Details
11.3.2 Basepaws Business Overview
11.3.3 Basepaws Pet Genetic Screening Platform Introduction
11.3.4 Basepaws Revenue in Pet Genetic Screening Platform Business (2021–2026)
11.3.5 Basepaws Recent Development
11.4 Orivet Genetic Pet Care
11.4.1 Orivet Genetic Pet Care Company Details
11.4.2 Orivet Genetic Pet Care Business Overview
11.4.3 Orivet Genetic Pet Care Pet Genetic Screening Platform Introduction
11.4.4 Orivet Genetic Pet Care Revenue in Pet Genetic Screening Platform Business (2021–2026)
11.4.5 Orivet Genetic Pet Care Recent Development
11.5 Paw Print Genetics
11.5.1 Paw Print Genetics Company Details
11.5.2 Paw Print Genetics Business Overview
11.5.3 Paw Print Genetics Pet Genetic Screening Platform Introduction
11.5.4 Paw Print Genetics Revenue in Pet Genetic Screening Platform Business (2021–2026)
11.5.5 Paw Print Genetics Recent Development
11.6 Animal Genetics
11.6.1 Animal Genetics Company Details
11.6.2 Animal Genetics Business Overview
11.6.3 Animal Genetics Pet Genetic Screening Platform Introduction
11.6.4 Animal Genetics Revenue in Pet Genetic Screening Platform Business (2021–2026)
11.6.5 Animal Genetics Recent Development
11.7 VetGen
11.7.1 VetGen Company Details
11.7.2 VetGen Business Overview
11.7.3 VetGen Pet Genetic Screening Platform Introduction
11.7.4 VetGen Revenue in Pet Genetic Screening Platform Business (2021–2026)
11.7.5 VetGen Recent Development
11.8 Antagene
11.8.1 Antagene Company Details
11.8.2 Antagene Business Overview
11.8.3 Antagene Pet Genetic Screening Platform Introduction
11.8.4 Antagene Revenue in Pet Genetic Screening Platform Business (2021–2026)
11.8.5 Antagene Recent Development
11.9 Laboklin
11.9.1 Laboklin Company Details
11.9.2 Laboklin Business Overview
11.9.3 Laboklin Pet Genetic Screening Platform Introduction
11.9.4 Laboklin Revenue in Pet Genetic Screening Platform Business (2021–2026)
11.9.5 Laboklin Recent Development
11.10 UC Davis
11.10.1 UC Davis Company Details
11.10.2 UC Davis Business Overview
11.10.3 UC Davis Pet Genetic Screening Platform Introduction
11.10.4 UC Davis Revenue in Pet Genetic Screening Platform Business (2021–2026)
11.10.5 UC Davis Recent Development
11.11 OptiGen
11.11.1 OptiGen Company Details
11.11.2 OptiGen Business Overview
11.11.3 OptiGen Pet Genetic Screening Platform Introduction
11.11.4 OptiGen Revenue in Pet Genetic Screening Platform Business (2021–2026)
11.11.5 OptiGen Recent Development
11.12 VHLGenetics
11.12.1 VHLGenetics Company Details
11.12.2 VHLGenetics Business Overview
11.12.3 VHLGenetics Pet Genetic Screening Platform Introduction
11.12.4 VHLGenetics Revenue in Pet Genetic Screening Platform Business (2021–2026)
11.12.5 VHLGenetics Recent Development
11.13 Sinogene
11.13.1 Sinogene Company Details
11.13.2 Sinogene Business Overview
11.13.3 Sinogene Pet Genetic Screening Platform Introduction
11.13.4 Sinogene Revenue in Pet Genetic Screening Platform Business (2021–2026)
11.13.5 Sinogene Recent Development
11.14 PawKnows
11.14.1 PawKnows Company Details
11.14.2 PawKnows Business Overview
11.14.3 PawKnows Pet Genetic Screening Platform Introduction
11.14.4 PawKnows Revenue in Pet Genetic Screening Platform Business (2021–2026)
11.14.5 PawKnows Recent Development
11.15 Circle Dog
11.15.1 Circle Dog Company Details
11.15.2 Circle Dog Business Overview
11.15.3 Circle Dog Pet Genetic Screening Platform Introduction
11.15.4 Circle Dog Revenue in Pet Genetic Screening Platform Business (2021–2026)
11.15.5 Circle Dog Recent Development
11.16 BGI Genomics
11.16.1 BGI Genomics Company Details
11.16.2 BGI Genomics Business Overview
11.16.3 BGI Genomics Pet Genetic Screening Platform Introduction
11.16.4 BGI Genomics Revenue in Pet Genetic Screening Platform Business (2021–2026)
11.16.5 BGI Genomics Recent Development
11.17 GENEWIZ
11.17.1 GENEWIZ Company Details
11.17.2 GENEWIZ Business Overview
11.17.3 GENEWIZ Pet Genetic Screening Platform Introduction
11.17.4 GENEWIZ Revenue in Pet Genetic Screening Platform Business (2021–2026)
11.17.5 GENEWIZ Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Pet Genetic Screening Platform market is projected to grow from US$ 1743 million in 2025 to US$ 4916 million by 2032, at a CAGR of 16.2% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-03-12
Pages: 158
USD 4900.00
(Single User License)
The global Pet Genetic Screening Platform market size was US$ 1743 million in 2025 and is forecast to reach a readjusted size of US$ 4916 million by 2032 with a CAGR of 16.2% during the forecast period 2026-2032.
Published Date: 2026-03-12
Pages: 108
USD 4250.00
(Single User License)
The global market for Pet Genetic Screening Platform was estimated to be worth US$ 1743 million in 2025 and is projected to reach US$ 4916 million, growing at a CAGR of 16.2% from 2026 to 2032.
Published Date: 2026-03-09
Pages: 135
USD 3950.00
(Single User License)
The global market for Pet Genetic Screening Platform was estimated to be worth US$ 1503 million in 2024 and is forecast to a readjusted size of US$ 4291 million by 2031 with a CAGR of 16.2% during the forecast period 2025-2031.
Published Date: 2025-10-10
Pages: 135
USD 3950.00
(Single User License)
The global Pet Genetic Screening Platform market size was US$ 1503 million in 2024 and is forecast to a readjusted size of US$ 4291 million by 2031 with a CAGR of 16.2% during the forecast period 2025-2031.
Published Date: 2025-10-10
Pages: 102
USD 4250.00
(Single User License)
The global market for Pet Genetic Screening Platform was valued at US$ 1503 million in the year 2024 and is projected to reach a revised size of US$ 4291 million by 2031, growing at a CAGR of 16.2% during the forecast period.
Published Date: 2025-10-10
Pages: 98
USD 2900.00
(Single User License)
The global Pet Genetic Screening Platform market is projected to grow from US$ 1503 million in 2024 to US$ 4291 million by 2031, at a CAGR of 16.2% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-10-10
Pages: 147
USD 4900.00
(Single User License)
The global Pet Genetic Screening Platform market is projected to grow from US$ 1743 million in 2025 to US$ 4916 million by 2032, at a CAGR of 16.2% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-03-12
Pages: 158
The global Pet Genetic Screening Platform market size was US$ 1743 million in 2025 and is forecast to reach a readjusted size of US$ 4916 million by 2032 with a CAGR of 16.2% during the forecast period 2026-2032.
Published: 2026-03-12
Pages: 108
The global market for Pet Genetic Screening Platform was estimated to be worth US$ 1743 million in 2025 and is projected to reach US$ 4916 million, growing at a CAGR of 16.2% from 2026 to 2032.
Published: 2026-03-09
Pages: 135
The global market for Pet Genetic Screening Platform was estimated to be worth US$ 1503 million in 2024 and is forecast to a readjusted size of US$ 4291 million by 2031 with a CAGR of 16.2% during the forecast period 2025-2031.
Published: 2025-10-10
Pages: 135
The global Pet Genetic Screening Platform market size was US$ 1503 million in 2024 and is forecast to a readjusted size of US$ 4291 million by 2031 with a CAGR of 16.2% during the forecast period 2025-2031.
Published: 2025-10-10
Pages: 102
The global market for Pet Genetic Screening Platform was valued at US$ 1503 million in the year 2024 and is projected to reach a revised size of US$ 4291 million by 2031, growing at a CAGR of 16.2% during the forecast period.
Published: 2025-10-10
Pages: 98
The global Pet Genetic Screening Platform market is projected to grow from US$ 1503 million in 2024 to US$ 4291 million by 2031, at a CAGR of 16.2% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-10-10
Pages: 147
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now